For example, , which is a targeted therapeutic agent for the targeted therapy of NSCLC, is a monoclonal antibody for VEGF. The gene VEGF is crucial because it is higher expressed in lung cancer than in normal lung [11]. Here, VEGFA is linked to non-small cell lung carcinoma.